The Vanguard Group Discloses Position in Spire Healthcare Group

The Vanguard Group, Inc. has released a Form 8.3 concerning its position in Spire Healthcare Group plc. The disclosure, made on April 1, 2026, details Vanguard's interest in relevant securities of the healthcare group, representing 3.59% of ordinary shares. This amounts to 14,458,121 shares held. The disclosure follows the rules of the Takeover Code.

On March 31, 2026, The Vanguard Group executed a sale of 9,275 of these '1p ordinary' shares at a unit price of 1.46 GBP. No cash-settled or stock-settled derivatives, options or other agreements related to these securities were reported. Furthermore, Vanguard has no indemnity or other dealing arrangements and no agreements related to voting rights or derivative transactions.

The disclosure ensures transparency regarding Vanguard’s position in relation to Spire Healthcare Group’s ongoing securities trade, as required by relevant regulations.